{"id":"W4405828684","doi":"10.1177/1877718x241300295","title":"Therapeutic modalities of deferiprone in Parkinson's disease: SKY and EMBARK studies","year":2024,"lang":"en","type":"article","venue":"Journal of Parkinson s Disease","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"Toronto Western Hospital; University Health Network; University of Alberta","funders":"Sanofi Genzyme; Horizon 2020 Framework Programme; Sun Pharma; Sunovion; H. Lundbeck A/S; Boston Scientific Corporation; EVER Neuro Pharma; Ipsen; Centre Hospitalier Universitaire de Toulouse; Servier; Acorda Therapeutics; Institut National de la Santé et de la Recherche Médicale; European Commission; Association France Parkinson; Agence Nationale de la Recherche; Parkinson's UK; Chiesi USA; Alexion Pharmaceuticals; Teva Pharmaceutical Industries; Pfizer; Biogen; Medtronic; Sanofi; Allergan; AstraZeneca; Direction de l’hospitalisation et de l’offre de Soins; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Deferiprone; Parkinson's disease; Medicine; Disease; Internal medicine; Deferoxamine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004408545,0.0003522861,0.0008139886,0.0005576088,0.00006115481,0.00005973527,0.0001286174,0.00006512184,0.00007877008],"category_scores_gemma":[0.0001701507,0.0002627128,0.0003763874,0.0003933878,0.0002022916,0.0003058718,0.00006617021,0.000255967,0.000008283463],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001994068,"about_ca_system_score_gemma":0.0005774579,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000110521,"about_ca_topic_score_gemma":0.000004920031,"domain_scores_codex":[0.9976307,0.0001508784,0.000770618,0.0003821384,0.0007021868,0.0003634693],"domain_scores_gemma":[0.9982017,0.0001629155,0.0002664951,0.0003044752,0.0002116877,0.0008526932],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01423749,0.003954192,0.8661405,0.008010949,0.005075796,0.02073542,0.002825073,0.000125736,0.002152586,0.006341427,0.0020192,0.06838159],"study_design_scores_gemma":[0.003598392,0.0005605525,0.8646274,0.002889736,0.002281992,0.00009828793,0.001072465,0.0007269792,0.0003533311,0.0109236,0.112542,0.0003252659],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7559254,0.2421311,0.0000665517,0.001030289,0.0003351656,0.000298945,0.0001001521,0.00002774629,0.00008459992],"genre_scores_gemma":[0.9845638,0.0142786,0.0002850219,0.000265961,0.0002206491,0.00003774642,0.000009525706,0.00005088398,0.0002878282],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2286384,"threshold_uncertainty_score":0.9999825,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03812069985095699,"score_gpt":0.3238525694828199,"score_spread":0.2857318696318629,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}